Drug efficacy reprogramming against aggressive human prostate cancer. Homo sapiens
收藏NIAID Data Ecosystem2026-03-07 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJNA152901
下载链接
链接失效反馈官方服务：
资源简介：
We enriched for prostate cancer cells by the selection system used in human iPS purification. Gene expression signature-based chemical prediction enabled us to identify candidate drugs for reverting the EOS (early transposon promoter, OCT4 and SOX2 enhancer) signature with chemoresistance into a chemosensitive phenotype. Overall design: We compared the gene expression between control and EOS-selected cancer cells.
创建时间：
2012-02-29
